Business · 05/12/2014Updated: 10/17/2026 · 1 min read
Mallinckrodt Inc. et al.; FDA Withdraws Approval of 23 New Drug Applications and 68 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of 23 new drug applications and 68 abbreviated new drug applications from multiple applicants, following written notifications from the applicants that the drug products are no longer marketed and requesting withdrawal of approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →